Company Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.
It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works.
The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates.
It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands.
The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015.
Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Country | Canada |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 960 |
CEO | Luc Mongeau |
Contact Details
Address: 1 Hershey Drive Smiths Falls, ON K7A 0A8 Canada | |
Phone | 855 558 9333 |
Website | canopygrowth.com |
Stock Details
Ticker Symbol | CGC |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | CAD |
CIK Code | 0001737927 |
CUSIP Number | 138035100 |
ISIN Number | CA1380357048 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Luc Mongeau | Chief Executive Officer and Director |
Dr. Christelle Gedeon L.L.B., Ph.D. | Chief Legal Officer and Corporate Secretary |
Thomas Carlton Stewart CPA | Interim Chief Financial Officer |
Bryan Murphy | Senior Vice President of Operations |
Jenny Brewer | Chief Human Resources Officer |
Jason Green | Head of Agriculture - Hemp Division |
Jurgen Bickel | MD and Co-Founder of STORZ and BICKEL GmbH |
Andrew Bevan | Senior Vice President of Medical Sales |
Tyler Burns | Director of Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 29, 2025 | 8-K | Current Report |
Jul 25, 2025 | PRE 14A | Other preliminary proxy statements |
Jul 9, 2025 | 8-K | Current Report |
Jun 6, 2025 | 424B7 | Filing |
Jun 6, 2025 | 424B5 | Filing |
Jun 4, 2025 | EFFECT | Notice of Effectiveness |
May 30, 2025 | POS AM | Post-Effective amendments for registration statement |
May 30, 2025 | 8-K | Current Report |
May 30, 2025 | 10-K | Annual Report |
May 29, 2025 | POSASR | Filing |